We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. General practitioners’ approaches to prostate-specific antigen testing in the north-east of the Netherlands

    Background

    There is wide variation in clinical practice for the early detection of prostate cancer, not least because of the ongoing debate about the...

    Sanny Kappen, Lisa Koops, ... Geertruida H. de Bock in BMC Family Practice
    Article Open access 17 December 2020
  2. Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses

    Bromo- and extra-terminal domain (BET) inhibitors represent potential therapeutic approaches in solid and hematological malignancies that are...

    Niklas Remke, Savita Bisht, ... Peter Brossart in Cancer Immunology, Immunotherapy
    Article 10 July 2020
  3. Predictive factors of tumor sink effect: Insights from 177Lu-Prostate-specific membrane antigen therapy

    Objective

    Tumor sink effect (TSE) has been defined as; decreased uptake in healthy tissue with increased tumor sequestration of the...

    Murat Tuncel, Tuğçe Telli, ... Erdem Karabulut in Annals of Nuclear Medicine
    Article 14 February 2021
  4. Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial

    Purpose

    We aimed to assess onabotulinumtoxinA treatment outcomes by sex in patients with overactive bladder (OAB) and then explore the impact of serum...

    Osamu Yokoyama, Masashi Honda, ... Takao Mogi in International Urology and Nephrology
    Article Open access 22 July 2021
  5. Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen

    Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein highly expressed by prostate cancer cells. PSMA-based radioligand therapy...

    Masayuki Inubushi, Hiroyuki Miura, ... Ryogo Minamimoto in Annals of Nuclear Medicine
    Article Open access 11 November 2020
  6. Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies

    Haploidentical allogeneic hematopoietic stem cell transplantation (Haplo-HSCT) has emerged as a novel strategy to treat patients suffering from...

    Junjie Cao, Renzhi Pei, ... Ying Lu in Annals of Hematology
    Article 06 July 2021
  7. Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigen

    Objective

    Up to 60% of patients with metastatic, castration-resistant prostate cancer (mCRPC) treated with 177 Lu prostate-specific membrane antigen...

    Kai Huang, Imke Schatka, ... Holger Amthauer in Annals of Nuclear Medicine
    Article Open access 22 December 2020
  8. Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males

    Background

    Prostate disorders are among the leading causes of morbidity and mortality in men above the age of 40 years globally. Serum...

    Maxwell Okuja, Faith Ameda, ... Samuel Bugeza in African Journal of Urology
    Article Open access 07 April 2021
  9. Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference

    Purpose

    Fluorine-18 ( 18 F) prostate–specific membrane antigen (PSMA) 1007 ( 18 F-PSMA-1007) is a radiotracer used in prostate cancer (PCa) staging. So...

    Rick Hermsen, Esmée B. C. Wedick, ... Jean-Paul A. van Basten in European Journal of Nuclear Medicine and Molecular Imaging
    Article 11 May 2022
  10. Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey

    Prostate-specific antigen (PSA) testing is one of the standard screening methods for prostate cancer (PC); however, a high proportion of men with...

    Jarrett A. Johnson, Richard P. Moser, ... Damali N. Martin in Journal of Community Health
    Article 16 October 2020
  11. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies

    Anti-Ro52 autoantibody (autoAb), highly prevalent in Sjogren’s syndrome (SjS) and systemic lupus erythematosus (SLE), is also frequent in systemic...

    Athanasios Gkoutzourelas, Christos Liaskos, ... Dimitrios P. Bogdanos in Rheumatology International
    Article 17 July 2020
  12. [68 Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma

    Purpose

    Prostate-specific membrane antigen (PSMA) is not only highly expressed on the surface prostate cancer cells but is also elevated during...

    Jolanta Kunikowska, Bartosz Cieślak, ... Leszek Królicki in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 03 September 2020
  13. Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis

    Purpose

    Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown promise for detecting nodal and distant prostate cancer...

    Sungmin Woo, Soleen Ghafoor, ... Hebert Alberto Vargas in European Journal of Hybrid Imaging
    Article Open access 09 September 2020
  14. Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran

    Background

    Prostate cancer (PCa) is the second most common malignancy in men worldwide and the incidence rate of PCa has been increasing in recent...

    Mehdi Mirzaei-Alavijeh, Farzad Jalilian, ... Farzaneh Solaimanizadeh in BMC Geriatrics
    Article Open access 24 August 2020
  15. Prostate-specific antigen increase after urethral catheterisation: fact or myth

    Background

    To find out any association of urethral catheterisation with rise in serum PSA.

    Methods

    This study was conducted in 80 patients of BPH who...

    Ajay Anand, Sonam Gupta in African Journal of Urology
    Article Open access 27 February 2021
  16. Bacillus subtilis spores as adjuvants against avian influenza H9N2 induce antigen-specific antibody and T cell responses in White Leghorn chickens

    Low-pathogenicity avian influenza H9N2 remains an endemic disease worldwide despite continuous vaccination, indicating the need for an improved...

    Ji Eun Lee, Yoon-Chul Kye, ... Cheol-Heui Yun in Veterinary Research
    Article Open access 24 May 2020
  17. Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27CD38+IFN-γ+CD4+ T cells for discrimination of active tuberculosis

    Background

    Active tuberculosis (ATB) originates from primary Mycobacterium tuberculosis (MTB) infection or reactivation of latent tuberculosis....

    Yong Fang, Na Wang, ... Wei Sha in BMC Infectious Diseases
    Article Open access 01 December 2022
  18. Multi-Specific CAR Targeting to Prevent Antigen Escape

    Purpose of Review

    Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable remission induction rates for relapsed/refractory B cell...

    Zachary Walsh, Savannah Ross, Terry J. Fry in Current Hematologic Malignancy Reports
    Article 22 July 2019
Did you find what you were looking for? Share feedback.